Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8989155 | 0.98 | IDO1 (0.44) | IDO1TAAR1GRIN2BGRIN1KMT2A | |
| SCHEMBL8491425 | 0.75 | SMN1; SMN2 (0.44) | GRIN2BGRIN1KMT2AMIFMAOB | |
| SCHEMBL30338779 | 0.74 | CA2 (0.51) | IDO1TAAR1GRIN2BGRIN1ALDH1A1 | |
| SCHEMBL8989195 | 0.74 | HTR3E (0.41) | IDO1TAAR1KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL9668695 | 0.74 | TAAR1 (0.40) | IDO1TAAR1GRIN2BGRIN1KMT2A | |
| Hydrochloric Acid SCHEMBL8488640 | 0.73 | SMN1; SMN2 (0.43) | GRIN2BGRIN1KMT2AMIFMAOB | |
| Hydrochloric Acid SCHEMBL8989160 | 0.73 | HTR3E (0.40) | IDO1MAOBKDM4EALDH1A1 | |
| SCHEMBL2096206 | 0.69 | TAAR1 (0.48) | IDO1TAAR1GRIN2BGRIN1KMT2A | |
| SCHEMBL20058285 | 0.69 | TAAR1 (0.48) | IDO1TAAR1GRIN2BGRIN1KMT2A | |
| SCHEMBL28096627 | 0.69 | MIF (0.48) | IDO1TAAR1GRIN2BGRIN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5545645-A | Heterocyclic derivatives in the treatment of ischaemia and related diseases | SYNTEX PHARMACEUTICALS, LIMITED (GB) | 1996-08-13 | — | — | US | disclosed |
| US-5428037-A | Piperazine derivatives; calcium and sodium channel antagonists | SYNTEX PHARMACEUTICALS, LTD. (GB) | 1995-06-27 | — | — | US | disclosed |